REGENERON PHARMACEUTICALS, INC.: net_income

Value{"amount": 3953600000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityREGENERON PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001804220-24-000009
Retrieved: 2026-08-19T08:39:12.123968+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000872589/net-income/2023-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/d526a775-8b7f-4c8d-8fa9-a221c26f0bbd

History